|
1
|
Frates MC, Benson CB, Doubilet PM,
Kunreuther E, Contreras M, Cibas ES, Orcutt J, Moore FD Jr, Larsen
PR, Marqusee E and Alexander EK: Prevalence and distribution of
carcinoma in patients with solitary and multiple thyroid nodules on
sonography. J Clin Endocrinol Metab. 91:3411–3417. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Morris LG, Tuttle RM and Davies L:
Changing trends in the incidence of thyroid cancer in the united
states. JAMA Otolaryngol Head Neck Surg. 142:709–711. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
La Vecchia C, Malvezzi M, Bosetti C,
Garavello W, Bertuccio P, Levi F and Negri E: Thyroid cancer
mortality and incidence: A global overview. Int J Cancer.
136:2187–2195. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Du L, Wang Y, Sun X, Li H, Geng X, Ge M
and Zhu Y: Thyroid cancer: Trends in incidence, mortality and
clinical-pathological patterns in Zhejiang Province, Southeast
China. BMC Cancer. 18:2912018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Karatzas T, Vasileiadis I, Zapanti E,
Charitoudis G, Karakostas E and Boutzios G: Thyroglobulin
antibodies as a potential predictive marker of papillary thyroid
carcinoma in patients with indeterminate cytology. Am J Surg.
212:946–952. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Azizi G and Malchoff CD: Autoimmune
thyroid disease: A risk factor for thyroid cancer. Endocr Pract.
17:201–209. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Vasileiadis I, Boutzios G, Charitoudis G,
Koukoulioti E and Karatzas T: Thyroglobulin antibodies could be a
potential predictive marker for papillary thyroid carcinoma. Ann
Surg Oncol. 21:2725–2732. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Spencer CA, Takeuchi M, Kazarosyan M, Wang
CC, Guttler RB, Singer PA, Fatemi S, LoPresti JS and Nicoloff JT:
Serum thyroglobulin autoantibodies: Prevalence, influence on serum
thyroglobulin measurement, and prognostic significance in patients
with differentiated thyroid carcinoma. J Clin Endocrinol Metab.
83:1121–1127. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kim ES, Lim DJ, Baek KH, Lee JM, Kim MK,
Kwon HS, Song KH, Kang MI, Cha BY, Lee KW and Son HY: Thyroglobulin
antibody is associated with increased cancer risk in thyroid
nodules. Thyroid. 20:885–891. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu Y, Li C, Zhao W and Wang Y:
Hashimoto's thyroiditis is an important risk factor of papillary
thyroid microcarcinoma in younger adults. Horm Metab Res.
49:732–738. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ernaga-Lorea A, Hernandez-Morhain MC,
Anda-Apinaniz E, Pineda-Arribas JJ, Migueliz-Bermejo I,
Eguílaz-Esparza N and Irigaray-Echarri A: Prognostic value of
change in anti-thyroglobulin antibodies after thyroidectomy in
patients with papillary thyroid carcinoma. Clin Transl Oncol.
20:740–744. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Trimboli P, Zilioli V, Imperiali M and
Giovanella L: Thyroglobulin autoantibodies before radioiodine
ablation predict differentiated thyroid cancer outcome. Clin Chem
Lab Med. 55:1995–2001. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wells GA, Shea B, O'Connell D, Peterson J,
Welch V, Losos M and Tugwell P: The Newcastle-Ottawa Scale (NOS)
for assessing the quality of nonrandomised studies in
meta-analyses. 2009, http://www.ohri.ca/programs/clinical_epidemiology/oxford.htm
|
|
15
|
Zhu C, Li S, Gao X, Zhu G, Song M and Gao
F: Retrospective analysis of thyroid nodules: Thyroid cancer risk
factors in suzhou, china. Clin Lab. 64:333–338. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu J, Zheng D, Li Q, Tang X, Luo Z, Yuan
Z, Gao L and Zhao J: A predictive model of thyroid malignancy using
clinical, biochemical and sonographic parameters for patients in a
multi-center setting. BMC Endocr Disord. 18:17–23. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhao H, Li H and Huang T: High urinary
iodine, thyroid autoantibodies, and thyroid-stimulating hormone for
papillary thyroid cancer risk. Biol Trace Elem Res. 184:317–324.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zeng R, Shou T, Yang KX, Shen T, Zhang JP,
Zuo RX, Zheng YQ and Yan XM: Papillary thyroid carcinoma risk
factors in the yunnan plateau of southwestern China. Ther Clin Risk
Manag. 12:1065–1074. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
He LZ, Zeng TS, Pu L, Pan SX, Xia WF and
Chen LL: Thyroid hormones, autoantibodies, ultrasonography, and
clinical parameters for predicting thyroid cancer. Int J
Endocrinol. 2016:82158342016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Qin J, Yu Z, Guan H, Shi L, Liu Y, Zhao N,
Shan Z, Han C, Li Y and Teng W: High thyroglobulin antibody levels
increase the risk of differentiated thyroid carcinoma. Dis Markers.
2015:6486702015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li T, Sheng J, Li W, Zhang X, Yu H, Chen
X, Zhang J, Cai Q, Shi Y and Liu Z: A new computational model for
human thyroid cancer enhances the preoperative diagnostic efficacy.
Oncotarget. 6:28463–28477. 2015.PubMed/NCBI
|
|
22
|
Grani G, Calvanese A, Carbotta G,
D'Alessandri M, Nesca A, Bianchini M, Del Sordo M, Vitale M and
Fumarola A: Thyroid autoimmunity and risk of malignancy in thyroid
nodules submitted to fine-needle aspiration cytology. Head Neck.
37:260–264. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Azizi G, Keller JM, Lewis M, Piper K,
Puett D, Rivenbark KM and Malchoff CD: Association of hashimoto's
thyroiditis with thyroid cancer. Endocr Relat Cancer. 21:845–852.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wu X, Lun Y, Jiang H, Gang Q, Xin S, Duan
Z and Zhang J: Coexistence of thyroglobulin antibodies and thyroid
peroxidase antibodies correlates with elevated thyroid-stimulating
hormone level and advanced tumor stage of papillary thyroid cancer.
Endocrine. 46:554–560. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lun Y, Wu X, Xia Q, Han Y, Zhang X, Liu Z,
Wang F, Duan Z, Xin S and Zhang J: Hashimoto's thyroiditis as a
risk factor of papillary thyroid cancer may improve cancer
prognosis. Otolaryngol Head Neck Surg. 148:396–402. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Boi F, Minerba L, Lai ML, Marziani B,
Figus B, Spanu F, Borghero A and Mariotti S: Both thyroid
autoimmunity and increased serum TSH are independent risk factors
for malignancy in patients with thyroid nodules. J Endocrinol
Invest. 36:313–320. 2013.PubMed/NCBI
|
|
27
|
Boelaert K, Horacek J, Holder RL,
Watkinson JC, Sheppard MC and Franklyn JA: Serum thyrotropin
concentration as a novel predictor of malignancy in thyroid nodules
investigated by fine-needle aspiration. J Clin Endocrinol Metab.
91:4295–4301. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lau J, Ioannidis JP, Terrin N, Schmid CH
and Olkin I: The case of the misleading funnel plot. BMJ.
333:597–600. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hosseini S, Payne RJ, Zawawi F, Mlynarek
A, Hier MP, Tamilia M and Forest VI: Can preoperative thyroglobulin
antibody levels be used as a marker for well differentiated thyroid
cancer? J Otolaryngol Head Neck Surg. 45:312016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gabalec F, Srbova L, Nova M, Hovorkova E,
Hornychova H, Jakubikova I, Ryska A and Cap J: Impact of
hashimoto's thyroiditis, TSH levels, and anti-thyroid antibody
positivity on differentiated thyroid carcinoma incidence.
Endokrynol Pol. 67:48–53. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Selek A, Cetinarslan B, Tarkun I, Canturk
Z, Ustuner B and Akyay Z: Thyroid autoimmunity: Is really
associated with papillary thyroid carcinoma? Eur Arch
Otorhinolaryngol. 274:1677–1681. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Donegan D, McIver B and
Algeciras-Schimnich A: Clinical consequences of a change in
anti-thyroglobulin antibody assays during the follow-up of patients
with differentiated thyroid cancer. Endocr Pract. 20:1032–1036.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
D'Aurizio F, Metus P, Ferrari A, Caruso B,
Castello R, Villalta D, Steffan A, Gaspardo K, Pesente F, Bizzaro
N, et al: Definition of the upper reference limit for thyroglobulin
antibodies according to the national academy of clinical
biochemistry guidelines: Comparison of eleven different automated
methods. Auto Immun Highlights. 8:82017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Pickett AJ, Jones M and Evans C: Causes of
discordance between thyroglobulin antibody assays. Ann Clin
Biochem. 49:463–467. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lee IS, Hsieh AT, Lee TW, Lee TI and Chien
YM: The association of thyrotropin and autoimmune thyroid disease
in developing papillary thyroid cancer. Int J Endocrinol.
2017:59403672017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhang L, Li H, Ji QH, Zhu YX, Wang ZY,
Wang Y, Huang CP, Shen Q, Li DS and Wu Y: The clinical features of
papillary thyroid cancer in hashimoto's thyroiditis patients from
an area with a high prevalence of hashimoto's disease. BMC Cancer.
12:6102012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Baser H, Topaloglu O, Tam AA, Evranos B,
Alkan A, Sungu N, Dumlu EG, Ersoy R and Cakir B: Higher TSH can be
used as an additional risk factor in prediction of malignancy in
euthyroid thyroid nodules evaluated by cytology based on bethesda
system. Endocrine. 53:520–529. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Fiore E, Rago T, Latrofa F, Provenzale MA,
Piaggi P, Delitala A, Scutari M, Basolo F, Di Coscio G, Grasso L,
et al: Hashimoto's thyroiditis is associated with papillary thyroid
carcinoma: Role of TSH and of treatment with L-thyroxine. Endocr
Relat Cancer. 18:429–437. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Latrofa F, Ricci D, Grasso L, Vitti P,
Masserini L, Basolo F, Ugolini C, Mascia G, Lucacchini A and
Pinchera A: Characterization of thyroglobulin epitopes in patients
with autoimmune and non-autoimmune thyroid diseases using
recombinant human monoclonal thyroglobulin autoantibodies. J Clin
Endocrinol Metab. 93:591–596. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Sinclair D: Clinical and laboratory
aspects of thyroid autoantibodies. Ann Clin Biochem. 43:173–183.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zhao L, Liu M, Gao Y, Huang Y, Lu G, Gao
Y, Guo X and She B: Glycosylation of sera thyroglobulin antibody in
patients with thyroid diseases. Eur J Endocrinol. 168:585–592.
2013. View Article : Google Scholar : PubMed/NCBI
|
